Meet Cardiogen: the cutting-edge synthetic peptide bioregulator designed to supercharge heart recovery post-myocardial infarction and bolster chronic heart failure management. By targeting cardiac fibroblasts and cardiomyocytes, it minimizes scarring and accelerates tissue repair for a healthier heart.
Mechanism
Cardiogen operates through innovative epigenetic modulation, fine-tuning gene expression in cardiac tissue. It boosts fibroblast activity, shields cardiomyocytes from damage, and prevents unnecessary cell death, ultimately enhancing tissue integrity and heart function. By managing fibroblast proliferation, Cardiogen combats pathological scarring and fosters the creation of crucial extracellular matrix components.
Research
Preliminary evidence from Russian animal studies suggests moderate cardiac protection; however, data on its efficacy in humans remains sparse. Further research is essential to confirm its mechanisms and establish long-term safety in Western populations, particularly for chronic heart failure and myocardial recovery.
Synergies
Maximize your recovery with Cardiogen paired with Vesugen for enhanced vascular support or other Khavinson peptides like Vilon for a comprehensive approach. Ben IQ customizes your stacking strategy based on YOUR unique labs and goals.
Trade-Offs
Despite its promise, Cardiogen is not yet FDA-approved and has limited interaction data. It's crucial to weigh potential interactions with other medications. Remember, your unique situation requires personalized data.